P339 Maintenance of nutritional parameters improvements over two years of elexacaftor/tezacaftor/ivacaftor (ETI) treatment according to severity of cystic fibrosis (CF) pulmonary disease.

Autor: Brignole, C.1 (AUTHOR), Guarise, R.1 (AUTHOR), Paiola, G.1 (AUTHOR), Lucca, F.1 (AUTHOR), Volpi, S.1 (AUTHOR), Signorini, M.1 (AUTHOR), Cipolli, M.1 (AUTHOR)
Zdroj: Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS172-S172. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: